All news

Manuel Luque appointed CEO of Rethink Medical

Manuel Luque, co-founder and CEO of Rethink Medical, speaking at a panel

Rethink Medical entered 2026 with a renewed leadership structure, with co-founder Manuel Luque assuming the role of CEO from 1 January 2026.

The transition marks a new stage for the company focused on execution, manufacturing readiness, commercial development and bringing T-Control® to healthcare markets.

More news

Alba Jiménez Martel, Industrial Engineer, at her desk in the Rethink Medical office

Rethink Medical strengthens its R&D team to advance T-Control® development

Rethink Medical has welcomed Industrial Engineer Alba Jiménez Martel to strengthen its innovation team and contribute to the development of a new catheterisation solution aimed at addressing complex urinary catheterisation situations. The project includes the design and development of a new catheter tip and is supported through the IPI programme.

IPI Project · ESF+